These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19127952)

  • 1. Delivering better medicines to children: need for better integration between the science, the policy, and the practice.
    Gazarian M
    Paediatr Drugs; 2009; 11(1):41-4. PubMed ID: 19127952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A landmark report on improving medicines for children.
    't Jong GW; Klassen TP; MacLeod SM
    JAMA Pediatr; 2015 Mar; 169(3):204-5. PubMed ID: 25561323
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The status of paediatric medicines initiatives around the world--What has happened and what has not?
    Hoppu K; Anabwani G; Garcia-Bournissen F; Gazarian M; Kearns GL; Nakamura H; Peterson RG; Sri Ranganathan S; de Wildt SN
    Eur J Clin Pharmacol; 2012 Jan; 68(1):1-10. PubMed ID: 21732178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting innovation and access to quality, safe, efficacious, and affordable medicines for children: A China approach on the 69
    Zhang L; Li B; Liu Z; Li M; Zheng H; Sun Y
    J Evid Based Med; 2017 May; 10(2):70-75. PubMed ID: 28452205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training pediatric clinical pharmacology and therapeutics specialists of the future: the needs, the reality, and opportunities for international networking.
    Gazarian M
    Paediatr Drugs; 2009; 11(1):63-6. PubMed ID: 19127959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential Medicines for Children.
    Hoppu K
    Clin Pharmacol Ther; 2017 Jun; 101(6):718-720. PubMed ID: 28182281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflection: medicines for children--science alone is not enough.
    Hoppu K
    Eur J Clin Pharmacol; 2013 May; 69 Suppl 1():59-63. PubMed ID: 23640189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global aspects of drug development.
    Hoppu K; Hogerzeil HV
    Handb Exp Pharmacol; 2011; 205():353-72. PubMed ID: 21882121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of promoting access to medicines in China - problems and recommendations.
    Sun J; Hu CJ; Stuntz M; Hogerzeil H; Liu Y
    BMC Health Serv Res; 2018 Feb; 18(1):125. PubMed ID: 29458428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping actions to improve access to medicines for mental disorders in low and middle income countries.
    Barbui C; Dua T; Kolappa K; Saraceno B; Saxena S
    Epidemiol Psychiatr Sci; 2017 Oct; 26(5):481-490. PubMed ID: 28067194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving availability and affordability of plasma-derived medicines.
    Cheraghali AM; Abolghasemi H
    Biologicals; 2010 Jan; 38(1):81-6. PubMed ID: 20137973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 25 years of the WHO essential medicines lists: progress and challenges.
    Laing R; Waning B; Gray A; Ford N; 't Hoen E
    Lancet; 2003 May; 361(9370):1723-9. PubMed ID: 12767751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential medicines for children.
    Hoppu K; Sri Ranganathan S
    Arch Dis Child; 2015 Feb; 100 Suppl 1():S38-42. PubMed ID: 25613966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian medicines regulators and payers.
    Pratt N; Camacho X; Vajdic C; Degenhardt L; Laba TL; Hillen J; Etherton-Beer C; Preen D; Jorm L; Donnolley N; Havard A; Pearson SA
    Int J Popul Data Sci; 2021; 6(3):1726. PubMed ID: 35784493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
    Adekola TA
    Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protection of the access to medicines right among disabled people.].
    Puzin SN; Grechko AV; Prianikov IV; Malichenko VS; Puzin SS
    Adv Gerontol; 2018; 31(4):581-587. PubMed ID: 30607924
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.